SPYGLASS PHARMA
Spyglass Pharma focuses on the development of novel treatments for chronic ophthalmic diseases based on technology. The company designs to deliver multiple drugs to address additional ophthalmic indications.
SPYGLASS PHARMA
Industry:
Delivery Medical Pharmaceutical
Founded:
2019-01-01
Address:
Aliso Viejo, California, United States
Country:
United States
Website Url:
http://www.spyglasspharma.com
Total Employee:
11+
Status:
Active
Contact:
+1 949 284 6904
Total Funding:
109.78 M USD
Technology used in webpage:
Euro Google Google Cloud
Similar Organizations
Aris Pharmaceuticals
Aris Pharmaceuticals provides medicinal chemistry services.
Birdi
Birdi provides online pharmacy services.
Campbell's Pharmacy
Campbell's Pharmacy provides pharmaceutical services.
Clinical Care Pharmacy
Clinical Care Pharmacy provides medication and pharmacy services.
Current Employees Featured
Founder
Investors List
RA Capital Management
RA Capital Management investment in Series C - Spyglass Pharma
Vertex Ventures HC
Vertex Ventures HC investment in Series C - Spyglass Pharma
New Enterprise Associates
New Enterprise Associates investment in Series C - Spyglass Pharma
Samsara BioCapital
Samsara BioCapital investment in Series C - Spyglass Pharma
Vensana Capital
Vensana Capital investment in Series C - Spyglass Pharma
Official Site Inspections
http://www.spyglasspharma.com Semrush global rank: 3.9 M Semrush visits lastest month: 2.92 K
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Spyglass Pharma"
About Us | Spyglass Pharma
As a member of the Global Leadership Team, Chief Medical Officer Leadership Team, Eye Care Commercial Leadership Team (ECLT), and Governance Boards, Jai collaborated with …See details»
Intraocular Drug Delivery That Lasts | Spyglass Pharma
ALISO VIEJO, Calif., November 19, 2024 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately-held ophthalmic biotechnology company, today announced completion of enrollment …See details»
Spyglass Pharma - Crunchbase Company Profile
Spyglass Pharma provides medicine for ophthalmic diseases. SpyGlass Pharma Drug Delivery Platform: A drug delivery system integrated with an intraocular lens (IOL) that releases medication over multiple years to treat glaucoma in …See details»
SpyGlass Pharma Company Profile | Management and Employees …
[email protected]: 4: first_last: [email protected]: 5: last: [email protected]: Your Questions, Our Answers Get Free Access to SpyGlass …See details»
SpyGlass Pharma, Inc. | LinkedIn
SpyGlass Pharma, Inc. Pharmaceutical Manufacturing Aliso Viejo, California 2,623 followers SpyGlass is developing novel treatments for chronic ophthalmic diseases.See details»
SpyGlass Pharma, Inc. Information - RocketReach
SpyGlass Pharma was Co-founded by Dr. Malik Y. Kahook, MD and Glenn Sussman. The company is focused on the development of novel treatments for chronic ophthalmic diseases …See details»
SpyGlass Pharma - PitchBook
SpyGlass Pharma General Information Description. Developer of ophthalmic devices and drug delivery platform designed to improve vision and eye care of patients. The company's devices …See details»
SpyGlass Pharma, Inc. Overview | SignalHire Company Profile
SpyGlass Pharma was Co-founded by Dr. Malik Y. Kahook, MD and Glenn Sussman. The company is focused on the development of novel treatments for chronic ophthalmic diseases …See details»
SpyGlass Pharma - Overview, News & Similar companies - ZoomInfo
Jul 10, 2023 SpyGlass Pharma contact info: Phone number: (949) 284-6904 Website: www.spyglasspharma.com What does SpyGlass Pharma do? SpyGlass Pharma was co …See details»
Contact - Spyglass Pharma
ALISO VIEJO, Calif., November 19, 2024 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately-held ophthalmic biotechnology company, today announced completion of enrollment …See details»
SpyGlass Pharma Strengthens Leadership to Further …
Dec 5, 2023 Margot Goodkin, M.D., Ph.D., Chief Medical Officer, SpyGlass Pharma Bilal Khan, MBA, CEO of New World Medical and SpyGlass Pharma Board of Directors Margot Goodkin, M ...See details»
SpyGlass Pharma Completes $90 Million Series C Financing to
Jul 10, 2023 www.spyglasspharma.com ALISO VIEJO, Calif. (PRWEB) July 10, 2023 -- SpyGlass Pharma, a privately-held ophthalmic therapeutics company, announced today …See details»
SpyGlass Pharma, Inc. Company Overview, Contact Details
Learn more about SpyGlass Pharma, Inc.'s company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
SpyGlass Pharma Strengthens Leadership to Further Advance
Dec 5, 2023 Margot Goodkin, M.D., Ph.D., appointed Chief Medical Officer; Bilal Khan, MBA, CEO of New World Medical, appointed to the SpyGlass Board of DirectorsSee details»
For Patients - Spyglass Pharma
ALISO VIEJO, Calif., November 19, 2024 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately-held ophthalmic biotechnology company, today announced completion of enrollment …See details»
SpyGlass Pharma - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and …See details»
SpyGlass Pharma Presents Compelling 3-Month Data from the …
Sep 29, 2022 Data from a First-in-Human feasibility trial to treat glaucoma demonstrated a 45% drop in mean intraocular pressure at 3 months. SpyGlass Pharma presented its innovative …See details»
Our Technology | Spyglass Pharma
ALISO VIEJO, Calif., November 19, 2024 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately-held ophthalmic biotechnology company, today announced completion of enrollment …See details»
SpyGlass Pharma Unveils Compelling 1-Year Data of Its Innovative …
Apr 2, 2024 SpyGlass Pharma, Inc. Share. Mean intraocular pressure (IOP) reduction from washed-out baseline was 44.6% at Month 12; all patients had IOP reduction >20% and IOP ≤ …See details»
Pipeline - Spyglass Pharma
ALISO VIEJO, Calif., November 19, 2024 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately-held ophthalmic biotechnology company, today announced completion of enrollment …See details»